Literature DB >> 21391854

Stem cell technology for the study and treatment of motor neuron diseases.

J Simon Lunn1, Stacey A Sakowski, Thais Federici, Jonathan D Glass, Nicholas M Boulis, Eva L Feldman.   

Abstract

Amyotrophic lateral sclerosis and spinal muscular atrophy are devastating neurodegenerative diseases that lead to the specific loss of motor neurons. Recently, stem cell technologies have been developed for the investigation and treatment of both diseases. Here we discuss the different stem cells currently being studied for mechanistic discovery and therapeutic development, including embryonic, adult and induced pluripotent stem cells. We also present supporting evidence for the utilization of stem cell technology in the treatment of amyotrophic lateral sclerosis and spinal muscular atrophy, and describe key issues that must be considered for the transition of stem cell therapies for motor neuron diseases from bench to bedside. Finally, we discuss the first-in-human Phase I trial currently underway examining the safety and feasibility of intraspinal stem cell injections in amyotrophic lateral sclerosis patients as a foundation for translating stem cell therapies for various neurological diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21391854      PMCID: PMC3154698          DOI: 10.2217/rme.11.6

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  119 in total

1.  A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III).

Authors: 
Journal:  Neurology       Date:  1999-04-22       Impact factor: 9.910

Review 2.  Guidelines and techniques for the generation of induced pluripotent stem cells.

Authors:  Nimet Maherali; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-12-04       Impact factor: 24.633

3.  Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS.

Authors:  Cédric Raoul; Toufik Abbas-Terki; Jean-Charles Bensadoun; Sandrine Guillot; Georg Haase; Jolanta Szulc; Christopher E Henderson; Patrick Aebischer
Journal:  Nat Med       Date:  2005-03-13       Impact factor: 53.440

4.  Beta-lactam antibiotics are multipotent agents to combat neurological diseases.

Authors:  Hong-Fang Ji; Liang Shen; Hong-Yu Zhang
Journal:  Biochem Biophys Res Commun       Date:  2005-08-05       Impact factor: 3.575

5.  Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.

Authors:  Ningzhe Zhang; Mahru C An; Daniel Montoro; Lisa M Ellerby
Journal:  PLoS Curr       Date:  2010-10-28

6.  Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation.

Authors:  Svitlana Garbuzova-Davis; Alison E Willing; Tanja Zigova; Samuel Saporta; Eleanor B Justen; Jennifer C Lane; Jennifer E Hudson; Ning Chen; Cyndy D Davis; Paul R Sanberg
Journal:  J Hematother Stem Cell Res       Date:  2003-06

7.  Human neural stem cell grafts in the spinal cord of SOD1 transgenic rats: differentiation and structural integration into the segmental motor circuitry.

Authors:  Leyan Xu; David K Ryugo; Tan Pongstaporn; Karl Johe; Vassilis E Koliatsos
Journal:  J Comp Neurol       Date:  2009-06-01       Impact factor: 3.215

Review 8.  Strategies and new developments in the generation of patient-specific pluripotent stem cells.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

9.  Functional recovery in rats with ischemic paraplegia after spinal grafting of human spinal stem cells.

Authors:  D Cizkova; O Kakinohana; K Kucharova; S Marsala; K Johe; T Hazel; M P Hefferan; M Marsala
Journal:  Neuroscience       Date:  2007-05-23       Impact factor: 3.590

10.  Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis.

Authors:  Lin Chen; Hongyun Huang; Jian Zhang; Feng Zhang; Yancheng Liu; Haitao Xi; Hongmei Wang; Zheng Gu; Yinglun Song; Ying Li; Ke Tan
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2007-09
View more
  32 in total

Review 1.  Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.

Authors:  Ying Liu; Wenbin Deng
Journal:  Brain Res       Date:  2015-09-28       Impact factor: 3.252

Review 2.  Intraspinal stem cell transplantation for amyotrophic lateral sclerosis.

Authors:  Kevin S Chen; Stacey A Sakowski; Eva L Feldman
Journal:  Ann Neurol       Date:  2016-02-12       Impact factor: 10.422

Review 3.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 4.  Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Authors:  Anthony W S Chan
Journal:  ILAR J       Date:  2013

5.  Induction of human umbilical Wharton's jelly-derived mesenchymal stem cells toward motor neuron-like cells.

Authors:  Zohreh Bagher; Somayeh Ebrahimi-Barough; Mahmoud Azami; Hamid Mirzadeh; Mansooreh Soleimani; Jafar Ai; Mohammad Reza Nourani; Mohammad Taghi Joghataei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-07-07       Impact factor: 2.416

6.  Long-term effects of intravitreal injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-SCID mice with acute ischemia-reperfusion injury.

Authors:  Susanna S Park; Sergio Caballero; Gerhard Bauer; Bradley Shibata; Alan Roth; Paul G Fitzgerald; Krisztina I Forward; Ping Zhou; Jeannine McGee; David G Telander; Maria B Grant; Jan A Nolta
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

7.  Intraspinal transplantation of neurogenin-expressing stem cells generates spinal cord neural progenitors.

Authors:  J Simon Lunn; Crystal Pacut; Emily Stern; Stacey A Sakowski; J Matthew Velkey; Sue O'Shea; Eva L Feldman
Journal:  Neurobiol Dis       Date:  2012-01-08       Impact factor: 5.996

Review 8.  Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future.

Authors:  J Simon Lunn; Stacey A Sakowski; Eva L Feldman
Journal:  Stem Cells       Date:  2014-05       Impact factor: 6.277

9.  Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis.

Authors:  Nicole L Nichols; Genevieve Gowing; Irawan Satriotomo; Lisa J Nashold; Erica A Dale; Masatoshi Suzuki; Pablo Avalos; Patrick L Mulcrone; Jacalyn McHugh; Clive N Svendsen; Gordon S Mitchell
Journal:  Am J Respir Crit Care Med       Date:  2012-12-06       Impact factor: 21.405

10.  Inhibitor of PI3K/Akt Signaling Pathway Small Molecule Promotes Motor Neuron Differentiation of Human Endometrial Stem Cells Cultured on Electrospun Biocomposite Polycaprolactone/Collagen Scaffolds.

Authors:  Somayeh Ebrahimi-Barough; Elham Hoveizi; Meysam Yazdankhah; Jafar Ai; Mehrdad Khakbiz; Faezeh Faghihi; Roksana Tajerian; Neda Bayat
Journal:  Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.